BIOA BioAge Labs, Inc.
Nasdaq · SEC CIK 1709941 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $7.79M 9 sales by 4 insiders
- Filings on record
- 49 since 2024-09-27, latest 2026-07-01 16:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Fortney Kristen | CEO, Dir | — | $4.22M |
| Barton Shane | Principal Accounting Off | — | $1.58M |
| RUBIN PAUL D | Chief Medical Off | — | $1.46M |
| GOLDSTEIN DOV A MD | CFO | — | $531.8K |
Transactions 32
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | Barton Shane | Principal Accounting Off | M - OptEx | $6.58 | +59.9K | 20.2K | New | +$394.6K |
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | Barton Shane | Principal Accounting Off | S - Sale+OE | $25.20 | -62.6K | 0 | -100% | -$1.58M |
| D | 2026-04-24 16:19 | 2026-04-23 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 36.6K | +11% | +$15.5K |
| DMT | 2026-04-03 16:07 | 2026-04-01 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $5.05 | +8,820 | 8,820 | New | +$44.6K |
| DT | 2026-04-03 16:07 | 2026-04-01 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $17.81 | -8,820 | 0 | -100% | -$157.1K |
| D | 2026-03-03 | 2026-03-01 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 33.0K | +12% | +$15.5K |
| DM | 2026-03-03 | 2026-03-02 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2026-03-03 | 2026-03-02 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $20.30 | -7,433 | 0 | -100% | -$150.9K |
| D | 2026-02-03 | 2026-02-02 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $18.75 | -7,433 | 0 | -100% | -$139.4K |
| DM | 2026-02-03 | 2026-02-02 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2026-02-03 | 2026-02-01 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,541 | 29.5K | +14% | +$15.5K |
| D | 2026-01-21 | 2026-01-16 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 25.9K | +16% | +$15.5K |
| DM | 2026-01-15 | 2026-01-13 | BIOA | GOLDSTEIN DOV A MD | CFO | S - Sale+OE | $19.70 | -27.0K | 40.4K | -40% | -$531.8K |
| D | 2026-01-15 | 2026-01-13 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $8.39 | +27.0K | 49.4K | +120% | +$226.5K |
| 2026-01-15 | 2026-01-13 | BIOA | Fortney Kristen | CEO, Dir | S - Sale | $18.12 | -233.1K | 976.9K | -19% | -$4.22M | |
| D | 2026-01-06 | 2026-01-02 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $12.85 | -7,433 | 0 | -100% | -$95.5K |
| DM | 2026-01-06 | 2026-01-02 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2025-12-11 | 2025-12-09 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $12.00 | -18.0K | 0 | -100% | -$216.0K |
| D | 2025-12-11 | 2025-12-09 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $6.57 | +18.0K | 18.0K | New | +$118.3K |
| D | 2025-12-05 | 2025-12-04 | BIOA | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.11 | +68.9K | 68.9K | New | +$283.2K |
| D | 2025-12-05 | 2025-12-04 | BIOA | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $10.19 | -68.9K | 0 | -100% | -$702.1K |
| A | 2025-03-10 | 2024-09-27 | BIOA | Hemrajani Rekha | Dir | P - Purchase | $18.00 | +3,000 | 3,000 | New | +$54.0K |
| 2025-03-10 | 2024-09-27 | BIOA | Barton Shane | Principal Accounting Off | P - Purchase | $18.00 | +2,632 | 2,632 | New | +$47.4K | |
| MI | 2024-10-03 | 2024-10-01+ | BIOA | Pande Vijay Satyanand | Dir | P - Purchase | $19.75 | +219.2K | 1.12M | +24% | +$4.33M |
| DI | 2024-10-01 | 2024-09-27 | BIOA | Chen Bihua | Former 10% Owner | P - Purchase | $18.00 | +450.0K | 1.63M | +38% | +$8.10M |
| DI | 2024-10-01 | 2024-09-27 | BIOA | Chen Bihua | Former 10% Owner | C - Cnv Deriv | — | +1.18M | 1.18M | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | HEALY JAMES | Dir | C - Cnv Deriv | — | +1.64M | 1.64M | New | — |
| DMI | 2024-09-27 | 2024-09-27 | BIOA | HEALY JAMES | Dir | P - Purchase | $18.00 | +666.7K | 11.1K | New | +$12.00M |
| DMI | 2024-09-27 | 2024-09-27 | BIOA | Pande Vijay Satyanand | Dir | C - Cnv Deriv | — | +2.11M | 655.3K | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | Pande Vijay Satyanand | Dir | P - Purchase | $18.00 | +900.0K | 900.0K | New | +$16.20M |
| DI | 2024-09-27 | 2024-09-27 | BIOA | ENRIGHT PATRICK G | Dir | C - Cnv Deriv | — | +1.31M | 1.31M | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | ENRIGHT PATRICK G | Dir | P - Purchase | $18.00 | +400.0K | 1.71M | +31% | +$7.20M |
Purchase Sale Sale after option exercise All abbreviations